Regencell Bioscience Holdings (RGC) Total Liabilities (2020 - 2025)

Regencell Bioscience Holdings' Total Liabilities history runs 6 years deep, the most recent figure standing at $1.8 million for Q4 2025.

• Quarterly Total Liabilities changed N/A year-over-year to $1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.8 million (changed N/A YoY) and the FY2025 annual result came in at $895308.0, up 307.86% from the prior year.
• Total Liabilities was $1.8 million for Q4 2025 at Regencell Bioscience Holdings, up from $895308.0 in the prior quarter.
• Across five years, Total Liabilities topped out at $4.3 million in Q2 2021 and bottomed at $219512.0 in Q2 2024.
• A 5-year average of $1.5 million and a median of $916670.0 in 2022 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities plunged 78.38% — and 2025, when it surged 307.86%.
• Regencell Bioscience Holdings' Total Liabilities stood at $4.3 million in 2021, then plunged by 78.38% to $938032.0 in 2022, then tumbled by 32.59% to $632320.0 in 2023, then sank by 65.28% to $219512.0 in 2024, then jumped by 717.27% to $1.8 million in 2025.
• Business Quant data shows RGC's Total Liabilities at $1.8 million in Q4 2025, $895308.0 in Q2 2025, and $219512.0 in Q2 2024.